Cargando…
Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis
As liver hepatocellular carcinoma (LIHC) has high morbidity and mortality rates, improving the clinical diagnosis and treatment of LIHC is an important issue. The advent of the era of precision medicine provides us with new opportunities to cure cancers, including the accumulation of multi-omics dat...
Autores principales: | Ouyang, Xiao, Fan, Qingju, Ling, Guang, Shi, Yu, Hu, Fuyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566011/ https://www.ncbi.nlm.nih.gov/pubmed/32899915 http://dx.doi.org/10.3390/genes11091051 |
Ejemplares similares
-
Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning
por: Wang, Jiaying, et al.
Publicado: (2022) -
Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma
por: Liu, Xiao, et al.
Publicado: (2022) -
Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model
por: Suter, Polina, et al.
Publicado: (2022) -
Integrated Multiple “-omics” Data Reveal Subtypes of Hepatocellular Carcinoma
por: Liu, Gang, et al.
Publicado: (2016) -
Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Lai, Ming-Wei, et al.
Publicado: (2022)